Hello, I am the founder and CEO of OyaGen, Inc (
www.oyageninc.com). We are a biotech specializing in oral and injectable drug discovery and development for the treatment of viral infectious diseases such as COVID and Ebola and a functional cure for HIV/AIDS. We have a lead compound that is a broad spectrum antiviral shown to be highly effective against COVID and Ebola and is predicted to be active against numerous unrelated virus. We also have a lead the has curative potential for HIV and for preventing viral rebound upon a scheduled interruption of therapy. The company’s platform technology has been developed over the 20 years the company has been in business. The leads are patented and published in peer reveiwed journals
Our goal is to finalize IND enabling studies, obtain an IND, conduct phase I Clinical trials and partner with Pharm as soon as possible. This activity would be supported by the first tranche of investment.
Our drug discovery pipeline has been supported by $12M of Angel investments and Federal grants.
Ready to Ask For Funding for your company?
Post a Funding Request